维普中文期刊产品整合服务
65篇 您的检索式:作者名="Wildiers"
    题名 作者 年代 出处 被引量
1Acute Radiation Effects on Cardiac Function Detected by Strain Rate Imaging in Breast Cancer Patients显示文摘Katrien Erven Ruxandra Jurcut Caroline Weltens Sorin Giusca Joris Ector Hans Wildiers Walter Van den Bogaert Jens-Uwe Voigt 2011International Journal of Radiation Oncology, Biology, Physics2011,,5:2
2Multicenter phase 1I randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER-2-negative metastatic breast cancer 显示文摘Wildiers H Fontaine C Vuylsteke P 2010Breast Cancer Res Treat2010,123,2:1
3Neoadjuvant capecitabine and docetaxel (plus trastuzumab): an effective non-anthracy-cline-based chemotherapy regimen for patients with locally ad-vanced breast cancer显示文摘Wildiers H Neven P Christiaens MR 2011Ann Oncol2011,22,3:1
4Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists ( EUSOMA ) 显示文摘Biganzoli L Wildiers H Oakman C 2012Lancet Oncol2012,13,4:1
5Vascular endothelial growth factor and angiogenesis显示文摘Hoeben A Landuyt B Highley MS Wildiers H Van Oosterom AT De Bruijn EA 2004Pharmacol Rev2004,56,4:1
6Atropine,hyoscine butylbromide,or scopolamine are equally effective for the treatment of death rattle in terminal care显示文摘Wildiers H Dhaenekint C Demeulenaere P 0,,01:1
7Relationship between age and axillary lymph node involvement in women with breast cancer显示文摘Wildiers H van C.alster B van de Poll-Franse LV 0,,18:1
8Markagement of breast cancer in elderly individuals : reeormnendations of the international so- ciety of geriatric oneology显示文摘Wildiers H Kunkler I Biganzoli L 2007Lancet Oncol2007,8,12:1
9Delivery of adjuvant sequentialdose-dense FEC-Doc to patients with breast cancer is feasible,butdose reductions and toxicity are dependent on treatment sequence显示文摘Wildiers H Dirix L Neven P 2009Breast Cancer Res Treat2009,114,1:1
10Doxorubicin vs epirubicin, report of a second-line randomized phase Ⅱ/Ⅲ study in advanced breast cancer 显示文摘Bontenbal M Andersson M Wildiers J 1998Br J Cancer1998,77,12:1
11Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequence显示文摘Wildiers H Ahmed B Guetens G 2004Eur J Cancer2004,40,2:1
12Detection and monitoring of cardiotoxicity-what does modern cardiology offer?显示文摘Jurcut R Wildiers H Ganame J 2008Support Care Cancer2008,16,5:1
13Detection and monitoring of cardiotoxicity-what does modern cardiology offer显示文摘Jurcut R Wildiers H Ganame J 0,,05:1
14Triple-negative breast cancer显示文摘STOCKMANS G DERAEDT K WILDIERS H 2008Curr Opin Oncol2008,20,6:1
15Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11 显示文摘Wildiers H Guetens G De Boeck G 2003Br J Cancer2003,88,12:1
16Continuing chemotherapy or not after the induction treatment in advanced breast cancer patients显示文摘M.A Nooij J.C.J.M de Haes L.V.A.M Beex J Wildiers J Klijn D Becquart J Jassem E Engelsman L Duchateau 2003European Journal of Cancer2003,,5:1
17Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer显示文摘Jurcut R Wildiers H Ganame J 2008J Am Soc Echocardiogr2008,21,12:1
18Combretastatin A-4 phosphate enhances CPT-11 activity independently of the administration sequence显示文摘WILDIERS H AHMED B GUETENS G 2004Eur J Cancer2004,40,2:1
19A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients显示文摘Wildiers H Jurcut R Ganame J 2008Crit Rev Oncol Hematol2008,67,2:1
20VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials显示文摘Diether Lambrechts Bart Claes Paul Delmar Joke Reumers Massimiliano Mazzone Betül T Yesilyurt Roland Devlieger Chris Verslype Sabine Tejpar Hans Wildiers Sanne de Haas Peter Carmeliet Stefan J Scherer Eric Van Cutsem 2012Lancet Oncology2012,,7:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费